- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Methods, 130, S. 63-71
- Ereignis
-
Veröffentlichung
- (wo)
-
Augsburg
- (wer)
-
Universität Augsburg
- (wann)
-
2017
- Ereignis
-
Veröffentlichung
- (wo)
-
Amsterdam
- (wer)
-
Elsevier
- (wann)
-
2017
- Urheber
-
Buck, Andreas K.
Stolzenburg, Antje
Hänscheid, Heribert
Schirbel, Andreas
Lückerath, Katharina
Schottelius, Margret
Wester, Hans-Jürgen
Lapa, Constantin Frederik Victor
- DOI
-
10.1016/j.ymeth.2017.09.002
- URN
-
urn:nbn:de:bvb:384-opus4-630165
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:53 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Buck, Andreas K.
- Stolzenburg, Antje
- Hänscheid, Heribert
- Schirbel, Andreas
- Lückerath, Katharina
- Schottelius, Margret
- Wester, Hans-Jürgen
- Lapa, Constantin Frederik Victor
- Universität Augsburg
- Elsevier
Entstanden
- 2017
Ähnliche Objekte (12)
Interobserver agreement rates on C-X-C Motif chemokine receptor 4–directed molecular imaging and therapy
Chemokine receptor 4 expression in primary Sjögren's syndrome
Intraindividual tumor heterogeneity in NET: further insight by C-X-C motif chemokine receptor 4-directed imaging [Image of the Month]
Side effects of CXC-chemokine receptor 4: directed endoradiotherapy with Pentixather prior to hematopoietic stem cell transplantation
[68Ga]Pentixafor–positron emission tomography/computed tomography detects chemokine receptor CXCR4 expression after ischemic stroke
C-X-C motif chemokine receptor 4-targeted radioligand therapy in patients with advanced T-cell lymphoma
[68Ga]Pentixafor-PET/CT for imaging of chemokine receptor 4 expression after myocardial infarction [Letter]
Peptide receptor radionuclide therapy for sarcoidosis
Somatostatin receptor-directed molecular imaging for therapeutic decision-making in patients with medullary thyroid carcinoma
Any decline in prostate-specific antigen levels identifies survivors scheduled for prostate-specific membrane antigen-directed radioligand therapy
Investigating the chemokine receptor 4 as potential theranostic target in adrenocortical cancer patients
68Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in Glioblastoma
Interobserver agreement rates on C-X-C Motif chemokine receptor 4–directed molecular imaging and therapy
Chemokine receptor 4 expression in primary Sjögren's syndrome
Intraindividual tumor heterogeneity in NET: further insight by C-X-C motif chemokine receptor 4-directed imaging [Image of the Month]
Side effects of CXC-chemokine receptor 4: directed endoradiotherapy with Pentixather prior to hematopoietic stem cell transplantation
[68Ga]Pentixafor–positron emission tomography/computed tomography detects chemokine receptor CXCR4 expression after ischemic stroke
C-X-C motif chemokine receptor 4-targeted radioligand therapy in patients with advanced T-cell lymphoma
[68Ga]Pentixafor-PET/CT for imaging of chemokine receptor 4 expression after myocardial infarction [Letter]
Peptide receptor radionuclide therapy for sarcoidosis
Somatostatin receptor-directed molecular imaging for therapeutic decision-making in patients with medullary thyroid carcinoma
Any decline in prostate-specific antigen levels identifies survivors scheduled for prostate-specific membrane antigen-directed radioligand therapy
Investigating the chemokine receptor 4 as potential theranostic target in adrenocortical cancer patients
68Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in Glioblastoma
Interobserver agreement rates on C-X-C Motif chemokine receptor 4–directed molecular imaging and therapy
Chemokine receptor 4 expression in primary Sjögren's syndrome
Intraindividual tumor heterogeneity in NET: further insight by C-X-C motif chemokine receptor 4-directed imaging [Image of the Month]
Side effects of CXC-chemokine receptor 4: directed endoradiotherapy with Pentixather prior to hematopoietic stem cell transplantation
[68Ga]Pentixafor–positron emission tomography/computed tomography detects chemokine receptor CXCR4 expression after ischemic stroke
C-X-C motif chemokine receptor 4-targeted radioligand therapy in patients with advanced T-cell lymphoma
[68Ga]Pentixafor-PET/CT for imaging of chemokine receptor 4 expression after myocardial infarction [Letter]
Peptide receptor radionuclide therapy for sarcoidosis
Somatostatin receptor-directed molecular imaging for therapeutic decision-making in patients with medullary thyroid carcinoma
Any decline in prostate-specific antigen levels identifies survivors scheduled for prostate-specific membrane antigen-directed radioligand therapy
Investigating the chemokine receptor 4 as potential theranostic target in adrenocortical cancer patients